Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan L Goldstein

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Expert Opinion on Biological Therapy|August 1, 2018
Thymosin β4 limits inflammation through autophagyGiorgia Renga, Vasilis Oikonomou, Claudia Stincardini, et al.
Biotechniques|March 30, 2007
Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expressionXueyan Bai, Jun Wu, Qiuyang Zhang, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Cellular proteostasis: a new twist in the action of thymosin α1Claudia Stincardini, Giorgia Renga, Valeria Villella, et al.
Life Science Alliance|August 21, 2020
Thymosin α1 protects from CTLA-4 intestinal immunopathologyGiorgia Renga, Marina M Bellet, Marilena Pariano, et al.
Life Science Alliance|November 14, 2019
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous diseaseGiorgia Renga, Vasilis Oikonomou, Silvia Moretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Nature Medicine|June 24, 2018
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Nature Medicine|April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Nature Medicine|June 24, 2018
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Expert Opinion on Biological Therapy|August 1, 2018
Thymosin β4 limits inflammation through autophagyGiorgia Renga, Vasilis Oikonomou, Claudia Stincardini, et al.
Biotechniques|March 30, 2007
Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expressionXueyan Bai, Jun Wu, Qiuyang Zhang, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Cellular proteostasis: a new twist in the action of thymosin α1Claudia Stincardini, Giorgia Renga, Valeria Villella, et al.
Life Science Alliance|August 21, 2020
Thymosin α1 protects from CTLA-4 intestinal immunopathologyGiorgia Renga, Marina M Bellet, Marilena Pariano, et al.
Life Science Alliance|November 14, 2019
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous diseaseGiorgia Renga, Vasilis Oikonomou, Silvia Moretti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Nature Medicine|June 24, 2018
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Nature Medicine|April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Nature Medicine|June 24, 2018
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisLuigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
Pageof 3